Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2286117 |
| _version_ | 1797511175864320000 |
|---|---|
| author | Wei Pan Diao Yu Na Shi Zheng Bao |
| author_facet | Wei Pan Diao Yu Na Shi Zheng Bao |
| author_sort | Wei Pan |
| collection | DOAJ |
| first_indexed | 2024-03-10T05:41:43Z |
| format | Article |
| id | doaj.art-dd449edc549b43f5981a7b990001c0f3 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-10T05:41:43Z |
| publishDate | 2023-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-dd449edc549b43f5981a7b990001c0f32023-11-22T22:30:47ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-12-0119310.1080/21645515.2023.2286117Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: CorrespondenceWei Pan0Diao Yu1Na Shi2Zheng Bao3Department of Clinical Laboratory, Haiyan People’s Hospital, Haiyan, Zhejiang, ChinaDepartment of Clinical Laboratory, Zhejiang Provincial People’s Hospital Bijie Hospital, Bijie, Guizhou, ChinaDepartment of Clinical Laboratory, Second Sanatorium of Air Force Healthcare Center for Special Services, Hangzhou, Zhejiang, ChinaDepartment of Clinical Laboratory, Xiangshan Red Cross Taiwan Compatriot Hospital, Xiangshan, Zhejiang, Chinahttps://www.tandfonline.com/doi/10.1080/21645515.2023.2286117Hemolysishereditary spherocytosisCOVID-19mRNA vaccine |
| spellingShingle | Wei Pan Diao Yu Na Shi Zheng Bao Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence Human Vaccines & Immunotherapeutics Hemolysis hereditary spherocytosis COVID-19 mRNA vaccine |
| title | Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence |
| title_full | Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence |
| title_fullStr | Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence |
| title_full_unstemmed | Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence |
| title_short | Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence |
| title_sort | progression of hemolysis in a patient with hereditary spherocytosis after the second dose of covid 19 mrna vaccine correspondence |
| topic | Hemolysis hereditary spherocytosis COVID-19 mRNA vaccine |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2023.2286117 |
| work_keys_str_mv | AT weipan progressionofhemolysisinapatientwithhereditaryspherocytosisaftertheseconddoseofcovid19mrnavaccinecorrespondence AT diaoyu progressionofhemolysisinapatientwithhereditaryspherocytosisaftertheseconddoseofcovid19mrnavaccinecorrespondence AT nashi progressionofhemolysisinapatientwithhereditaryspherocytosisaftertheseconddoseofcovid19mrnavaccinecorrespondence AT zhengbao progressionofhemolysisinapatientwithhereditaryspherocytosisaftertheseconddoseofcovid19mrnavaccinecorrespondence |